|
Could I order a new chequebook, please? http://www.caughtinthecrossfire.com/stmap_d6540.html?levitra.evista.lithobid mapharmacieprivileges.fr Iclusig, whose generic name is ponatinib, is a kinase inhibitor that is currently approved to be used to treat chronic myeloid leukemia and Philadelphia-chromosome positive acute lymphoblastic leukemia. The company is working with the FDA on revised product labeling to reflect recent safety findings in the trial that were the basis of marketing approvals.
|